The 36-month beta value for IMNN is also noteworthy at 2.04. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for IMNN is 17.74M, and at present, short sellers hold a 22.32% of that float. The average trading volume of IMNN on June 26, 2025 was 11.04M shares.
IMNN) stock’s latest price update
The stock price of Imunon Inc (NASDAQ: IMNN) has dropped by -3.23 compared to previous close of 0.84. Despite this, the company has seen a fall of -19.13% in its stock price over the last five trading days. globenewswire.com reported 2025-06-18 that ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO
IMNN’s Market Performance
IMNN’s stock has fallen by -19.13% in the past week, with a monthly drop of -64.37% and a quarterly drop of -22.24%. The volatility ratio for the week is 10.33% while the volatility levels for the last 30 days are 30.81% for Imunon Inc The simple moving average for the last 20 days is -43.96% for IMNN’s stock, with a simple moving average of -15.87% for the last 200 days.
IMNN Trading at -25.46% from the 50-Day Moving Average
After a stumble in the market that brought IMNN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.84% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IMNN starting from Braun Donald P, who purchase 25,000 shares at the price of $1.18 back on Aug 20 ’24. After this action, Braun Donald P now owns 25,597 shares of Imunon Inc, valued at $29,480 using the latest closing price.
Lindborg Stacy, the President and CEO of Imunon Inc, purchase 25,000 shares at $0.98 during a trade that took place back on Aug 15 ’24, which means that Lindborg Stacy is holding 264,166 shares at $24,500 based on the most recent closing price.
Stock Fundamentals for IMNN
The total capital return value is set at -17.15. Equity return is now at value -397.54, with -167.96 for asset returns.
Based on Imunon Inc (IMNN), the company’s capital structure generated 0.69 points at debt to capital in total, while cash flow to debt ratio is standing at -15.7.
Currently, EBITDA for the company is -17.98 million with net debt to EBITDA at 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.88.
Conclusion
In summary, Imunon Inc (IMNN) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
